The role of real-world data and real-world evidence in advancing regulatory science and targeted therapeutics: a narrative review from the United States perspective

Emily Nagel, Youssef M. Roman

Open source

DOI
10.1080/17410541.2026.2655298
Published
2026-03-04
Container
Personalized Medicine
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/17410541.2026.2655298,
  title = {The role of real-world data and real-world evidence in advancing regulatory science and targeted therapeutics: a narrative review from the United States perspective},
  author = {Emily Nagel and Youssef M. Roman},
  year = {2026},
  journal = {Personalized Medicine},
  doi = {10.1080/17410541.2026.2655298},
  url = {https://doi.org/10.1080/17410541.2026.2655298}
}

RIS

TY  - JOUR
TI  - The role of real-world data and real-world evidence in advancing regulatory science and targeted therapeutics: a narrative review from the United States perspective
AU  - Emily Nagel
AU  - Youssef M. Roman
PY  - 2026
JO  - Personalized Medicine
DO  - 10.1080/17410541.2026.2655298
UR  - https://doi.org/10.1080/17410541.2026.2655298
ER  - 

APA

Nagel, E., & Roman, Y. M. (2026). The role of real-world data and real-world evidence in advancing regulatory science and targeted therapeutics: a narrative review from the United States perspective. Personalized Medicine. https://doi.org/10.1080/17410541.2026.2655298

Source records